Last updated on September 2017

Study of LLG783 in Patients With Peripheral Artery Disease (PAD) and Intermittent Claudication

Brief description of study

This study is designed to determine whether LLG783 displays the clinical safety and efficacy profile, after multiple i.v. doses, to support further development in patients with PAD and intermittent claudication.

Clinical Study Identifier: NCT03194776


Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Novartis Pharmaceuticals

Novartis Investigative Site
Jacksonville, FL United States
  Connect »